Ofatumumab & Ibrutinib + Allogeneic Bone Marrow Transplant or Consolidation in High Risk Chronic Lymphocytic Leukemia
Clinical trial NCT02388048 · COMPLETED
Trial details
- NCT number
- NCT02388048
- Sponsor
- Gruppo Italiano Malattie EMatologiche dell'Adulto
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-01
- Primary completion
- 2024-04-03
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.